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Abstract
Background: Previous work has established that HGF/c-Met signaling plays a pivotal role in regulating the onset of S phase
following partial hepatectomy (PH). In this study, we used Met
fl/fl;Alb-Cre
+/2 conditional knockout mice to determine the
effects of c-Met dysfunction in hepatocytes on kinetics of liver regeneration.
Methodology/Principal Finding: The priming events appeared to be intact in Met
fl/fl;Alb-Cre
+/2 livers. Up-regulation of stress
response (MAFK, IKBZ, SOCS3) and early growth response (c-Myc, c-Jun, c-Fos, DUSP1 and 6) genes as assessed by RT-qPCR and/
or microarray profiling was unchanged. This was consistent with an early induction of MAPK/Erk and STAT3. However, after a
successful completion ofthefirstround of DNA replication, c-Metdeficient hepatocyteswere blocked inearly/midG2phase as
shown by staining with phosphorylated form of histone H3. Furthermore, loss of c-Met in hepatocytes diminished the
subsequent G1/S progression and delayed liver recovery after partial hepatectomy. Upstream signaling pathways involved in
the blockage of G2/M transition included lack of persistent Erk1/2 activation and inability to up-regulate the levels of Cdk1,
Plk1, Aurora A and B, and Mad2 along with a defective histone 3 phosphorylation and lack of chromatin condensation.
Continuous supplementation with EGF in vitro increased proliferation of Met
fl/fl;Alb-Cre
+/2 primary hepatocytes and partially
restored expression levels of mitotic cell cycle regulators albeit to a lesser degree as compared to control cultures.
Conclusion/Significance: In conclusion, our results assign a novel non-redundant function for HGF/c-Met signaling in
regulation of G2/M gene expression program via maintaining a persistent Erk1/2 activation throughout liver regeneration.
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Introduction
Liver regeneration after partial hepatectomy (PH) is a process of
compensatory hyperplasia which involves all cell types within the
remaining liver lobes and depends on the multitude of interrelated
regulatory pathways that directly or indirectly control successful
restoration of hepatic mass [1–3]. The major conceptual advances as
set forth by Nelson Fausto categorize the signaling pathways into
cytokine, growth factor and metabolic networks integrating
reparative proliferation with continuation of hepatic function [2].
According to the model, liver regeneration starts from the activation
of immediate early response genes driven primarily by tumor
necrosis factor-a (TNF-a) and interleukin 6 (IL-6), which are
produced by nonparenchymal cells and prime quiescent hepatocytes
for the transition into G1 stage. Among the major growth factors
involved at this stage is the hepatocyte growth factor (HGF) [4].
HGF is a mesenchyme-derived multifunctional molecule that
elicits its activities through a single receptor c-Met [5,6]. Due to
the multitude of HGF/c-Met functions, including regulation of
mitogenesis, motogenesis, and morphogenesis, HGF signaling is
considered to be a primary stimulator of liver regeneration.
Accordingly, hepatic overexpression of HGF remarkably acceler-
ated whereas loss of c-Met signaling decreased regenerative
potential of liver [7–10].
A key step in c-Met signaling is HGF-induced phosphorylation
of the kinase domain followed by autophosphorylation and
activation of numerous downstream effectors [11,12]. The best
known for its role in the initiation of S phase is mitogen-activated
protein kinase (MAPK)/Erk pathway. Gene knockout studies in
rodents confirmed the central role of c-Met in cell cycle initiation
and progression. Recent work by Borowiak and colleagues has
shown that conditional inactivation of c-met using a ubiquitously
expressed alpha/beta interferon-inducible promoter resulted in
suppressed Erk1/2 activation and defective exit from quiescence in
regenerating mouse liver [7]. Similarly, Michalopoulos’ group
found a blocked entry into the cell cycle and increased apoptosis
during the first 24 hr of rat liver regeneration by silencing c-met
via RNA interference [9]. Both approaches caused inactivation of
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12739c-met in diverse liver cell types, and therefore the extent to which
the lack of c-Met signaling specifically in hepatocytes contributed
to impaired cell cycle regulation could not be elucidated. Further,
although prior evidence implicated Erk1/2 pathway in regulating
G1/S transition, its role during G2/M transition and how it
relates to c-Met function remains to be fully realized.
To address these questions, we designed our experiments using
two c-Met conditional knockout models: a hepatocyte- and liver
specific mutant mice in which the exon encoding the ATP-binding
site of c-met was deleted either by a constitutive Alb-Cre or inducible
Mx1-Cre transgenes. Here we report for the first time that besides
its role in G1/S progression, c-Met is essential regulator of G2/M
progression through a mechanism involving Erk1/2-dependent
activation of key mitotic regulators including Cdk1, Plk1, and
Aurora A and B.
Results
c-Met is not Required for Postnatal Liver Growth
To elucidate the mechanism of growth regulation by c-Met
specifically in hepatocytes, we used a hepatocyte-specific c-Met
conditional knockout mouse model described previously [8]. In
these mice, the deletion of the exon encoding the ATP-binding site
of c-met is achieved by constitutively active Alb-Cre transgene and
thus restricted to hepatocytes whereas nonparenchymal liver cells
are not targeted. The lack of c-Met expression in hepatocytes was
confirmed by PCR analysis and immunohistochemistry (Figure
S1A and B). Mice with a selective disruption of c-met in hepatocytes
appeared normal without apparent histological abnormalities.
Although liver mass was slightly reduced, there were no differences
in blood parameters or ploidy as estimated at 2 months of age,
indicating that c-Met deficiency did not affect the postnatal liver
growth (Figure S1D and E).
Loss of c-Met Delays Recovery of Liver Mass after Partial
Hepatectomy
To investigate the requirement for c-Met function during liver
regeneration, we performed a standard 70% hepatectomy using
Met
wt/wt;Alb-Cre
+/2 and Met
fl/fl;Alb-Cre
+/2 mice. Even though
Met
fl/fl;Alb-Cre
+/2 mice were more sensitive to metafane anesthesia
[8], there was no difference in the accumulated postoperative
survival during the first week after surgery when we used a mixture
of isoflurane/oxygen for anesthesia and kept the gall bladder intact
(96.9% in control versus 94.3% and c-Met mutant mice). The
serum levels of aspartate aminotransferase were also not different
at 24 hr and 48 hr after PH reflecting a comparable tissue injury
in mice of both genotypes (Figure S2A). Histological examination
of the regenerative livers also revealed neither increased cell death
nor presence of necrosis suggesting that loss of c-Met function did
not interfere with hepatocyte survival after PH. Nonetheless, a
regeneration index calculated as an increase in liver-to-body mass
ratio was lower in c-Met mutant mice and reached only
77.264.3% of the original liver mass after 168 hr as compared
to 93.663.3% in controls (Figure S2B). Blood levels of albumin
and triglyceride were also decreased indicating that c-Met
knockout mice could not regenerate liver mass and function
efficiently (Figure S2C and D).
c-Met Regulates both G1/S and G2/M Transitions
To evaluate the effect of c-met deletion on cell cycle progression,
we used 5-bromo-29-deoxyuridine (BrdU) immunohistochemistry
and mitotic frequency. A quantitative time course of BrdU
incorporation showed that kinetics of DNA synthesis was
conserved within the first 36 hr after PH but the peak level was
significantly reduced in c-Met mutant livers (Figure 1A). However,
despite normal exit from quiescence and progression through the
G1/S phases, the first wave of mitoses was both remarkably
decreased and delayed (Figure 1B). Immunostaining with
additional markers of cell cycle progression confirmed almost
complete lack of mitosis in c-Met mutant livers at this time point
(Figure 1C). Eventually, c-Met deficient hepatocytes entered
mitosis albeit at a significantly reduced frequency (Figure 1B).
Thus, analysis of cell cycle progression indicates that lack of c-Met
function in hepatocytes inhibited cell proliferation through a
combination of an initial G2/M block followed by a decreased
entry into next G1 phase.
c-Met Deficient Hepatocytes Are Blocked in Early/Mid G2
To determine more precisely when c-Met activity is required for
transition into mitosis, we examined histone H3 phosphorylation
as a differential marker for G2 and M phase cells. Histone H3
phosphorylation on Serine 10 (H3-P) represents a key step in
chromosome remodeling during cell division [13]. It begins during
early G2 in pericentric foci well before chromosome condensation
is microscopically evident and reaches maximal levels in
metaphase chromosome [14]. Immunoflourescence detection
and quantitative assessment of H3-P staining revealed that the
number of cells displaying a punctuate pattern of staining
progressively increased in mice of both genotypes within the fist
24–36 hr as cells were completing the S phase and entering G2
phase. However, Met
fl/fl;Alb-Cre
+/2 hepatocytes did not acquire a
strong genome-wide H3-P required for chromosome condensation
and mitotic onset and did not advance into mitosis (Figure 1D and
E). These data suggest that c-Met deficient hepatocytes were
blocked in early/mid G2 phase due to failure of mitosis-specific
phosphorylation events responsible for chromosome compaction.
Deregulation of Genes Involved in G2/M Progression
To address the molecular basis of the early G2 block, we next
examined the transcriptional response to partial hepatectomy
using gene expression profiling. RNA was isolated from liver
samples at various time-points of liver regeneration including the
initial or priming phase (0.5, 2 hr) which allows rapid activation of
transcription factors promoting G0-G1 transition of normally
quiescent hepatocytes [15], transition through G1 phase (12,
24 hr) and S/G2/M (36, 42, 48 hr) phases (Figure 1). Only genes
with more than 1.5-fold expression differences between control
and c-Met mutant mice in at least 80% of samples were included
in the list of significant genes. In agreement with cell kinetics data
(Figure 1A), the early priming events appeared to be unaffected by
the loss of c-Met signaling in hepatocytes consistent with the
previous work demonstrating that the massive changes in gene
expression in the first four hours after 2/3 PH, while preparing the
quiescent hepatocytes to enter cell cycle, cannot predict whether
DNA replication may actually occur [15]. Overall, there were no
significant variations in the early induction of several key
transcription factors involved in the initiation of hepatocyte pro-
liferation including c-Jun, c-Fos and c-Myc between Met
wt/wt;
Alb-Cre
+/2 and Met
fl/fl;Alb-Cre
+/2 mice (Figure 2A and Figure
S3). Also, both TNFa and IL6 responses appeared to be similar in
the knockouts as judged by a comparable induction of the known
feedback regulators of the major cytokine and growth factor
signaling pathways such as SOCS3, IGFR1, DUSP1 and DUSP 6.
Accordingly, mice of both genotypes exhibited a high degree of
Stat3 phosphorylation, an important downstream effector of IL6
signaling, which peaked at 4–6 hr after PH (Figure 2B).
Nonetheless, a subset of immediate-early genes implicated in the
control of cell cycle progression, such as c-Fos and Egr1, exhibited
c-Met and G2/M Progression
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12739Figure 1. Cell cycle progression defects in c-Met-deficient regenerating livers. (A) Normal induction of the first but reduced second wave
of DNA replication and (B) inhibition of mitosis in Met
fl/fl;Alb-Cre
+/2 livers. The labeling and mitotic indexes were calculated by randomly counting
BrdU-stained nuclei (A) and mitotic figures (B) in a total of 2,000 hepatocytes and expressed as percent. Results shown are the means 6 SE (n=527
mice/group/time point). Asterisks indicate statistical significance assessed by Student’s t- test (P,0.05). (C) Representative photomicrographs of
PCNA (top) and phosphor-histone H3 staining of liver sections. Shown are cells in S phase (arrows), G2 (G2), prophase (P) and metaphase (M). Scale
bars, 10 mm. (D and E) Block of G2/M transition in Met-deficient livers shown by staining with phosphor-histone H3. Positive cells were counted in
c-Met and G2/M Progression
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later time points of liver regeneration (Figure S3).
However, the greatest differences in gene expression were
detected at 36–48 hr when c-Met mutant cells were blocked in G2
phase. At this time, we identified 184 downregulated genes
promoted by the absence of c-Met (P#0.01) (Table S1, Figure 3A).
Ingenuity Pathway Analysis of the down-regulated genes revealed
that cell division, cell cycle, mitotic cell cycle, chromosome
segregation and chromosome organization belonged to the top ten
functions with the highest P-values (Figure 3B). Many of the
identified cell cycle genes were found to be associated with G2/M
cell cycle checkpoint/arrest including Fen1, Cdc25b, Mbd4, Egr1,
Ccnb1, Ccnb2, Plk4, Aurka, and Mad2L1. Notably, c-Met inactiva-
tion affected expression of genes involved in chromosome
congression, alignment and segregation (Esco2, SMC2, Nuf2). In
addition, we found downregulation of several genes encoding
kinetochore and centromere-associated proteins essential for
faithful chromosome segregation during mitotic progression, such
as Ndc80, Cenp-e,- g,- h,- k,- i and –q. Among those, Cenpe is a
kinesin-like motor protein which accumulates in G2 phase just
before the mitosis and required for the efficient recruitment of
BUBR1, MAD1 and MAD2 to kinetochores [16]. Many of the over-
represented genes with reduced expression are known to play
important roles in spindle organization and biogenesis including
Ect2, ASPM, Nusap1, Kif18a and Stmn1, 3, and 4. Furthermore, the
expression of common markers of checkpoint/arrest involved in
G1/S and S phase transition, such as Ccne, Ccnd, Gas1, and Dbf4,
was also decreased. This was consistent with the observation that
the number of S phase cells was reduced in c-Met mutant livers
after 36 hr of liver regeneration as cells failed to transit into next S
phase providing further support that c-Met deletion has a broad
impact on cell cycle progression (Figure 1).
Figure 2. Induction of genes associated with priming phase in c-Met mutant livers after partial hepatectomy. (A) Heatmap depicts a
subset of 20 genes that are commonly regulated in Met
wt/wt;Alb-Cre
+/2 and Met
fl/fl;Alb-Cre
+/2 mice within the first 2 hr of liver regeneration (1.5-fold,
P,0.01 in at least 80% of arrays). (B) Representative western blots and quantification of total and phosphorylated Stat3 protein levels relative to b-
actin. Results shown are the means 6 SE of 3 experiments.
doi:10.1371/journal.pone.0012739.g002
10–20 randomly selected fields in Met
wt/wt;Alb-Cre
+/2 (D) and Met
f/f;Alb-Cre
+/2 (E) liver sections under confocal microscope and expressed as percent
from a total of 600–2000 nuclei. Results shown are the means 6 SE (n=527 mice/group/time point).
doi:10.1371/journal.pone.0012739.g001
c-Met and G2/M Progression
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compare the differentially expressed genes in Met
fl/fl;Alb-Cre
+/2
regenerating livers against a gene set which was previously
identified as G2/M phase regulated in synchronized HeLa cells
[17]. This analysis revealed that more than a third of orthologous
genes (48/132) belonging to the G2/M cluster as defined by HeLa
expression data were significantly downregulated in Met
fl/fl;Alb-
Cre
+/2 mice at 36–48 hr (Figure S4). Thus, microarray profiling
proves consistent with the cell kinetics data and emphasizes a
previously unrecognized link between c-Met signaling and
regulation of genes functionally involved in G2/M progression.
G2 Block Correlates with the Lack of Erk1/2 Signaling
The critical role of c-Met in activation of the downstream
mediator Erk1/2 during liver regeneration has been established
using a liver-specific c-Met conditional knockout mouse model [7].
Therefore, the hepatocyte-specific c-Met conditional knockout
mice were also examined for the defects in the Erk1/2
phosphorylation. As expected, c-Met protein was not detectable
in whole cell lysates prepared from the mutant livers at any time
point during liver regeneration (Figure 4A). Deletion of c-Met in
hepatocytes did not affect the early phosphorylation of Erk1/2 at
6–12 hr following PH but it completely abolished the second peak
between 36–48 hr coincidently with a defective progression
through G2 phase of cell cycle (Figure 4A). Since Met
fl/fl;Alb-
Cre
+/2 hepatocytes express a kinase-inactive c-Met receptor which
is irresponsive to HGF stimulation [8], these data indicate that c-
Met signaling in hepatocytes is dispensable for initiation but
required for sustaining a long-term Erk1/2 phosphorylation
during liver regeneration.
Activation of other members of MAPK family, including a well
known regulator of G2/M transition p38 MAPK, appeared to be
normal. In addition, we observed only minimal if any changes in
phosphorylation of Akt, another important downstream mediator
of c-Met pathway. More significantly, there were no differences in
the expression of TGFa or phosphorylation of EGFR receptor
(Figure 4A) suggesting unique and important contribution of Met/
Erk signaling in the induction of genes functionally involved in
G2/M progression which is not compensated by other tyrosine
kinase receptors.
Ineffective Induction of Mitosis-Specific Kinases
Finally, we examined the protein levels of potential downstream
targets of MAPK/Erk pathway which control various events
during mitosis. We found a profound inhibition and delayed
recruitment of several classes of mitosis-specific serine/threonine
kinases including cdc2, Aurora A and B, and Plk1 (Figure 4B and
Figure S5). Specifically, the depletion of Aurora B kinase, which
associates with chromosomes during early mitosis as a part of
chromosomal passenger complex [18], was consistent with a
delayed histone H3 phosphorylation and failure of chromosome
condensation. In addition, the protein levels of Mad2, a key
component of the spindle checkpoint that inhibits anaphase
promoting complex [19], were also reduced (Figure S5). To
exclude the possibility that the lack of phosphorylation of mitotic
kinases was due to a secondary effects caused by long-term
adaptive changes in Met
fl/fl;Alb-Cre
+/2 mice, we repeated the
experiments using regenerating livers from Met
fl/fl;Mx1-Cre
+/2
conditional knockout mice. The results showed that cdc2 and
Aurora B expression were similarly repressed at 36–42 hr
concordant with the lack of ERK1/2 activation (Figure 4C).
We also used primary cultured hepatocytes to address the effect
of c-Met deficiency on proliferation and intracellular signaling.
The proliferation of primary hepatocytes in culture as well as
expression of cell cycle regulators were correspondingly compro-
mised in the absence of c-Met signaling (Figure 5A and B).
Continuous EGF stimulation for 72 hr was able to increase Erk1/
2 phosphorylation and restore both DNA synthesis and protein
levels of cdc2, Aurora A, Aurora B, and Mad1and 2 albeit to a
considerably lesser degree as compared to control hepatocytes,
again underscoring a key contribution of c-Met to maintaining an
adequate levels of cell proliferation.
Figure 3. Downregulation of genes involved in G2/M progres-
sion in Met
fl/fl;Alb-Cre
+/2 mice. (A) Expression profiles of 184 genes
encoding G2/M regulators based on the Ingenuity Pathway Analysis. (B)
The ten top-ranked Gene Ontology categories reflecting biological
changes in Met mutant livers. Only the GO categories that were
significantly underrepresented in Met livers are indicated together the
number of genes altered in each category (X-axis).
doi:10.1371/journal.pone.0012739.g003
c-Met and G2/M Progression
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Using regenerating mouse liver as a model of cell cycle
progression, we investigated the role for c-Met in hepatocyte
proliferation. We report that absence of c-Met signaling in
hepatocytes results in G2/M cell cycle arrest along with the lack
of Erk1/2 activation and downregulation of broad G2/M
regulatory networks. These results define a new critical function
for c-Met in G2/M transition and implicate Erk1/2 as a potential
G2/M target of c-Met pathway.
Until now, it was generally accepted that c-Met plays a pivotal
role in regulating onset of S phase. Our results support earlier
work describing the importance of Met/Erk1/2 in mitogenic
signaling during liver regeneration [7]. By employing a model
deficient for c-met exclusively in hepatocytes, we found that c-met
ablation affected neither early hepatic Erk1/2 activation nor
induction of the initial round of DNA replication. However, it
totally abrogated the second peak of Erk1/2 phosphorylation at
36–48 hr and delayed cell cycle progression from G2 to M phase.
The decrease in mitoses was followed by a reduced hepatocyte
entry into the next S phase indicating that c-Met controls cell cycle
progression at G1/S and G2/M check points. Interestingly, the
induction of immediate early genes c-Fos and Egr-1 which can
function as sensors for duration of Erk1/2 signaling [20] was
reduced in c-Met mutant mice, particularly at the later time points
of liver regeneration (Figure S3). Downregulation of Egr1 may be
of significance to c-Met phenotype since Egr1 is reported to be a
transcriptional target of HGF, and Egr1-null mice display a delayed
mitotic progression through defective spindle assembly checkpoint
[21].
A described block at the G2/M boundary contrasts with a
defective exit from quiescence and a complete lack of Erk1/2
activation observed in liver-specific c-Met conditional knockout
mice which lost c-Met mediated signaling in all cell types [7]. The
differences in the dynamics of Erk1/2 phosphorylation between
two c-Met conditional knockout models imply that alternative
pathways may account for the early Erk1/2 activation and that c-
Met signaling in hepatocytes is essential for sustaining long term
Erk1/2 activation throughout liver regeneration. It was suggested
that cross talk between two receptor tyrosine kinases, c-Met and
EGFR, may influence each other’s activities by affecting the
common downstream signaling pathways [22]. However, a
complete absence of EGFR in the liver was insufficient to suppress
c-Met and Erk1/2 activation [23] consistent with c-Met being a
major determinant of mitogen-activated protein kinase cascades in
regenerating liver [7]. Instead, lack of EGFR signaling in EGFR
fl/fl;
Mx1-Cre mutant livers reduced the cyclin D expression and blocked
G1/S transition due to the reduced NF-kB activation [23],
thus emphasizing the requirement of simultaneous co-
activation of parallel signaling pathways and coordinated
cellular responses for full mitogenic signaling and efficient
liver regeneration.
Figure 4. Downregulation of cell cycle regulated proteins in c-Met-deficient regenerating livers. (A and B) Whole cell lysates were
prepared from Met
wt/wt;Alb-Cre
+/2 and Met
fl/fl;Alb-Cre
+/2 livers at the indicated times and probed by Western blotting using the indicated antibodies.
(C) Western blotting of whole cell lysates prepared from Met
fl/fl and Met
fl/fl;Mx1-Cre
+/2 livers. Representative immunoblots are shown. Actin served as
a loading control.
doi:10.1371/journal.pone.0012739.g004
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hepatocytes is well known [24–26]. There is extensive evidence
that Erk1/2 activation is a prerequisite for G1 to S entry [27].
However, the contribution of Erk1/2 signaling to G2/M
progression is less defined and more controversial being either
stimulatory or inhibitory depending on the cell type and kinetics or
strength of Erk1/2 phosphorylation [28–30]. Our findings are in
agreement with the results of other studies demonstrating delayed
G2/M kinetics upon pharmacologic MAPK inhibition, siRNA-
mediated Erk1/2 knockdown, or dominant-negative Mek1/2 [31–
33]. Notably, c-Met deficient hepatocytes were incapable of
generating a sustained Erk1/2 signaling and after a successful
passage through the first S phase were blocked in early/mid G2
phase concomitantly with suppression of the core G2/M genes,
such as Egr1, Ccnb1, Ccnb2, Plks, Aurka, and Mad2L1 [19,34–37].
Inhibition of Erk1/2 activation was also associated with reduced
global histone H3 phosphorylation, essential for chromosome
condensation [13]. Accordingly, microarray profiling of c-Met
deficient regenerating livers revealed downregulation of genes
known to control chromosome congression, alignment and
segregation (Esco2, CENPs, SMC2, Nuf1, etc.) along with others
implicated in spindle organization and biogenesis (Ect2, ASPM,
Nusap1, and Stmn1, 3 and 4). In addition, Met
fl/fl;Alb-Cre
+/2 livers
displayed downregulation of Egr-1, an immediate early growth
response gene shown to be involved in the control of mitotic entry
through the spindle assembly checkpoint [21]. Western blot
analysis also revealed aberrant phosphorylation of stathmin, a
microtubule-destabilizing protein [38] (Figure 4A), pointing to c-
Met dependent structural changes as possible causes of delayed cell
cycle progression. Indeed, cell division, mitotic cell cycle and
chromosome segregation were among the top Gene Ontology
terms (Figure 3B).
Most significantly, and consistent with lack of Erk1/2
phosphorylation, we found a profound down-regulation of all
three classes of serine/threonine kinases that monitor various
aspects of mitosis, including Cdk1, Plk1 and two members of
Aurora family kinase, Aurora A and B (Figure 4). Among these,
Cdk1 is the main kinase player during G2/M transition [39]
which controls execution of a transcriptional program required for
mitosis through phosphorylation of Plk1 and Aurora B and
subsequent activation of FoxM1, a key transcription factor during
G2/M transition [35,40].
To compensate for the loss of Erk1/2 activation, hepatocyte
cultures established from Met
fl/fl;Alb-Cre
+/2 livers were grown in
the continuous presence of EGF. A persistent EGF supplementa-
tion in vitro was able only partially rescue the effect of Erk1/2
downregulation in c-Met depleted hepatocytes and restore to some
extent the levels of cdc2, Aurora A and B, and Mad2. These
results highlight a dominant role for c-Met signaling in
maintaining sufficient levels of Erk1/2 activation and suggest that
loss of Met/Erk1/2 signaling cascade is responsible for the c-Met
knockout phenotype. In conclusion, we report that c-Met function
in hepatocytes is required for direct activation of Erk1/2 at the
G2/M transition and coordinated control of G2/M transcription-
al program.
Materials and Methods
Ethics Statement
All experimental procedures were approved by the NCI-
Bethesda Animal Care and Use Committee (ACUC) under
LEC-038. The NCI animal program meets or exceeds require-
ments of the Public Health Service Policy on Humane Care and
Use of Animals and is fully accredited by AAALAC International.
Mice
Hepatocyte specific c-Met conditional knockout (Met
fl/fl;Alb-
Cre
+/2) and control (Met
wt/wt;Alb-Cre
+/2) mice were described
previously. Since deletion of floxed DNA in hepatocytes is time-
dependent [41], we used male mice at 8–10 weeks of age, when
cre-recombination is complete (Figure S1A). Genotyping was done
by PCR analysis on tail genomic DNA and specificity of the c-met
deletion was verified by immunohistochemistry. Expression of
Figure 5. Reduced DNA replication and diminished expression
of cell cycle proteins in c-Met deficient primary hepatocytes.
(A) Hepatocytes were isolated from 2-month-old Met
wt/wt;Alb-Cre
+/2
and Met
fl/fl;Alb-Cre
+/2 livers and cultured in the presence of HGF (40 ng/
ml), EGF (20 ng/ml) or HGF+EGF for 3 days. DNA replication was
analyzed by
3H-Thymidine incorporation expressed as counts per
minute per microgram of protein. Cells were exposed to
3H-Thymidin
for 24 hr before harvesting. Shown are the means 6 SE of duplicates
from 4 independent experiments. (B) Western blot analysis of whole cell
lysates with indicated antibodies. Cells were grown in the absence (NT)
or presence of HGF (H), EGF (E), and both (H+E) for 3 days. The
experiments were performed twice, and representative immunoblots
are shown. a-tubulin served as a loading control.
doi:10.1371/journal.pone.0012739.g005
c-Met and G2/M Progression
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fl/fl;Alb-Cre
+/2 hepatocytes and
limited to nonparenchymal liver cells (Figure S1B).
To achieve systemic deletion of c-met, Met
fl/fl mice [8] were bred
with homozygous Mx1-Cre mice expressing cre under the control of
type I IFN-inducible Mx1 promotor as described [7] to generate
Met
fl/fl;Mx1-Cre
+/2 mice. To activate Mx1 promotor, 8-week- old
male mice received three i.p. injections of 300 mg poly (I:C)
(Sigma-Aldrich) with a 2 day interval. Mx1-Cre-negative litter-
mates (Met
fl/fl) received equal amounts of poly (I:C) and served as
controls. The partial hepatectomy was performed 3 days after the
last injection. We used functional test to verify the efficient
inactivation of the c-met gene after Mx1-cre-induced recombination.
HGF mediated c-Met phosphorylation as well as downstream
signaling via Erk1/2 and Akt were completely abolished in
hepatocytes isolated from c-Met
fl/fl;Mx1-Cre
+/2 mice (Figure S1C).
Partial Hepatectomy (PH)
Mice were anesthetized with a mixture of isoflurane/oxygen,
and right medial, left medial, and left lateral lobes were excised
after separate ligations resulting in removal of ,70% of the
hepatic mass. A special care has been taken to preserve the
gallbladder. At least 5 animals were used for each time point.
Livers were harvested, weighed, and processed for subsequent
analysis. Preoperative and regenerated liver weight was expressed
as liver-to-body-weight ratio and used to calculate the relative
growth of residual liver lobes as the regenerated/preoperative liver
weight X 100%. Preoperative liver weight in untreated control
and mutant mice was 4.5 and 4.1 (P,0.05), respectively, reflecting
small albeit persistent differences in liver mass (Figure S1E).
Analysis of Liver Function
Blood samples were obtained from orbital venous plexus of 3
mice per time point under isoflurane anesthesia before sacrifice.
Serum levels of alanine aminotransferase (ALT), albumin, and
triglyceride, were measured using a Reflovet Plus bench top
analyzer (Roche) following manufacturer’s instructions.
BrdU Labeling and Immunohistochemistry
Mice received i.p. injections of 150 mg/g 5-bromo-29-deoxyur-
idine (BrdU) (Roche Applied Science) 2 hr before sacrifice. Livers
were fixed in alcoholic-formalin for 4–6 hr, 5-mm paraffin sections
were prepared and stained with ant-BrdU (1:100; Becton
Dickinson), anti-phosphor-histone H3 Ser10 (1:200; Cell Signal-
ing) or PCNA clone PC10 (1:200; DAKO Cytomation) and
examined with a Zeiss 510 confocal laser scanning microscope
(Carl Zeiss, Germany).
Western Blotting
Whole cell lysates (100 mg) were prepared from frozen tissues
using T-PER Tissue Extraction Buffer (Pierce) containing
Complete Protease Inhibitor Cocktail (Roche), separated by
SDS-PAGE and transferred onto Invitrolon PVDF (Invitrogen).
Membranes were blocked in 5% non-fat milk in Tris-buffered
saline containing 0.1% Tween 20 for 1 h and probed with specific
antibodies listed in Table S2. Immune complexes were detected
using the enhanced chemiluminescence system (Pierce).
Primary Hepatocyte Culture and [
3H]Thymidine
Incorporation
Hepatocytes were isolated from 2-month-old mice using a two-
step collagenase perfusion [8]. The rate of DNA synthesis was
measured by [methyl-3H]thymidine incorporation as described
[26]. Cells were incubated with 1 mCi of [methyl-3H]thymidine
(5 Ci/mmol) for 24 hr before cell harvesting, washed twice with
PBS, scrapped off the culture dish and divided for analysis of
protein content and [3H]thymidine counting using a MicroBeta
TriLux scintillation counter (Perkin Elmer).
Microarray Experiments and Data Analysis
Microarrays containing 21,997 long (65-mer) oligonucleotides
representing 19,740 unique genes were printed in the Laboratory
of Molecular Technology (National Cancer Institute). Total RNA
was isolated from frozen liver samples using TRIZOL (Invitrogen)
following the manufacture’s recommendation. Sample preparation
and array hybridization were performed as described [42]. Briefly,
20 mg of RNA were converted to cDNA, labeled with Cy-3 or Cy-
5 dye and hybridized together with common reference RNA in a
dye-swap design. The common reference RNA was pooled from
ten wild type B6/129 strain mouse livers. Gene expression values
defined as a sample-per-reference ratio [42] were normalized by
Loess and quantile methods across all samples [43,44] and log2
transformed. The microarray datasets have been deposited to
Gene Expression Omnibus database (http://www.ncbi.nlm.nih.
gov/geo, accession number GSE17609).
The cell cycle progression in the regenerative livers is only a
partially synchronized process. Therefore, to identify the biolog-
ically relevant gene expression changes, samples at early (30 min-
2 hr) and late (36–42–48 hr) time points were pooled together and
analyzed as single data sets to minimize the intrinsic variations
between different animals while increasing the statistical power of
comparison. Differentially expressed genes were selected across the
selected time points (early versus late) using bootstrap t-test [45]
with 6,000 repetitions (P#0.01) and at least 1.5 fold expression
changes between Met
fl/fl;Alb-Cre
+/2 and Met
wt/wt;Alb-Cre
+/2 mice.
All selected genes satisfied the criteria for false discovery rate of less
than 0.1 which was calculated using ‘‘fdrtool’’ R version 2.11.0 as
described [46]. RT-qPCR was performed for selected targets using
SYBR Green Master-Mix (Bio-Rad) to validate the microarray
results.
Data mining was performed using Ingenuity Pathway Analysis
tool (Ingenuity Systems Inc.). The significance of each network,
function, and pathway was determined by the scoring system
provided by Ingenuity. The differentially expressed genes were
compared with the genes which were previously identified as G2/
M phase regulated in synchronized HeLa cells [17]. Orthologous
genes between mouse and human microarrays were selected using
HomoloGene database of National Center for Biotechnology
Information (NCBI). The gene set enrichment analysis (GSEA)
was performed using GSEA v2.06 (Broad Institute, MIT).
Supporting Information
Figure S1 Selective disruption of c-Met in hepatocytes does not
affect postnatal liver growth. (A) PCR analysis of floxed c-met allele
(Met
fl/fl). Genomic DNA was isolated from livers at different age.
(B) Indirect immunofluorescence staining of liver sections with c-
Met antibody. Nuclear counterstaining was performed with DAPI.
Expression of c-Met was not detectable in Met
fl/fl;Alb-Cre
+/2
hepatocytes and limited to nonparenchymal liver cells (arrows).
Scale bar, 10 mM. (C) Western blots showing phosphorylation
status of c-Met, p42/p44 MAPK and Akt upon HGF stimulation
in pimary hepatocytes. Cells were isolated from adult Met
fl/fl and
Met
fl/fl;Mx1-Cre
+/2 livers using a two-step collagen perfusion
followed by isodensity centrifugation. After overnight incubation,
cells were synchronized by serum deprivation for 2 hrs and treated
with 50 ng/ml of rhHGF (PeproTech) for 5–30 min. Note that
HGF mediated c-Met phosphorylation as well as downstream
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c-Met
fl/fl;Mx1-Cre
+/2. (D) Representative FACS histograms of
DNA content and ploidy distribution in Met
wt/wt;Alb-Cre
+/2 and
Met
fl/fl;Alb-Cre
+/2 livers at 2 months of age. Freshly isolated
hepatocytes were stained with propidium iodine using the Cell
Cycle Test DNA Reagent Kit (Becton-Dickinson, San Jose, CA).
Nuclei DNA content was measured using a Becton-Dickinson
FACScan flow cytometer and Cell-Quest Sofware. 20,000 events
were collected. Results shown are the means 6 SE (n=3 mice
per group). (E) Liver/body weight ratios and blood bio-
chemistry. Serum was obtained from Met
wt/wt;Alb-Cre
+/2 and
Met
fl/fl;Alb-Cre
+/2 at 2 month of age. Results shown are the
means 6 SE (n=3 mice per group). Asterisk indicates statistical
significance assessed by Student’s t test (P,0.05). M, Marker;
AST, Aspartate aminotrasferase, ALT, Alanine aminotrasferase.
Found at: doi:10.1371/journal.pone.0012739.s001 (2.00 MB
PDF)
Figure S2 Loss of Met delays recovery of liver mass and function
after partial hepatectomy. (A) Serum levels of aspartate amino-
trasferase (AST) were indistinguishable in control and Met-
deficient mice indicating a similar extent of hepatic injury. (B)
Slower recovery of liver weight and reduced levels of albumin (C)
and triglyceride (D) in Met-deficient livers. Data are shown as the
means 6 SE (n=325/group per time point). Asterisks indicate
statistical significance assessed by Student’s t test (P is less than at
least 0.05).
Found at: doi:10.1371/journal.pone.0012739.s002 (0.33 MB
PDF)
Figure S3 Temporal profiles of mRNA levels of selected genes
during liver regeneration. The results from microarray and the
corresponding RT-qPCR analyses are shown in left and right
panels, respectively. Oligonucleotide primers were designed using
Primer3 v.0.4.0 (http://frodo.wi.mit.edu/primer3/). The amplifi-
cation protocol was as follows: 95uC for 3 min, followed by 40
cycles of 95uC for 15 seconds and 1 minute at 60uC, completed by
a dissociation curve to identify false positive amplicons. The
relative expression level of each gene was normalized to the
corresponding levels at 0 hr and calculated using the formula
2
(2DDCt). GAPDH and 18s RNAs were used as endogenous
reference. The data are presented as the means 6 SD (n=3).
Asterisks indicate statistical significance assessed by Student’s t test
(P is less than at least 0.05).
Found at: doi:10.1371/journal.pone.0012739.s003 (0.40 MB
PDF)
Figure S4 Gene set enrichment analysis (GSEA). This analysis
was performed to compare gene expression data of regenerating
mouse livers with a gene set identified as G2/M phase regulated in
synchronized HeLa cells {Whitfield, 2002 #17}. To explore the
enrichment of G2/M associated genes, we selected orthologous
genes between human and mouse microarrays using HomoloGene
database of National Center for Biotechnology Information
(NCBI). A total of 132 orthologous genes were present at the
G2/M stage. (A) Enrichment of the G2/M gene set in Met
fl/fl;Alb-
Cre
+/2 phenotype (normalized enrichment score, NES =4.23, P
value ,0.0001). (B) The expression values of 48 out of 132
orthologous genes involved in G2/M progression were signifi-
cantly downregulated in Met
fl/fl;Alb-Cre
+/2 mice at 36–48 hr.
Found at: doi:10.1371/journal.pone.0012739.s004 (0.28 MB
PDF)
Figure S5 Western blot analysis of cell cycle-associated genes
using nuclear extracts from timed liver samples after partial
hepatectomy. Samples were probed by Western blotting using the
indicated antibodies.
Found at: doi:10.1371/journal.pone.0012739.s005 (0.67 MB
PDF)
Table S1 List of genes differentially expressed in Met
fl/fl;Alb-
Cre
+/2 regenerating livers at 36–48 hr (.1.5 fold changes,
P,0.01).
Found at: doi:10.1371/journal.pone.0012739.s006 (0.20 MB
DOC)
Table S2 List of antibodies.
Found at: doi:10.1371/journal.pone.0012739.s007 (0.05 MB
DOC)
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